Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins

Li Wei Lo, Yao Chang Chen, Yi Jen Chen, Wanwarang Wongcharoen, Cheng I. Lin, Shih Ann Chen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The autonomic nervous system and calcium regulation play important roles in the pathophysiology of atrial fibrillation. Calmodulin regulates the calcium homeostasis and may mediate the proarrhythmic effects of autonomic nervous agents. The purpose of this study was to compare the effects of β- and α-adrenoceptor agonists on the pulmonary vein electrical activity and evaluate whether calmodulin kinase II inhibitors may change the effects of the adrenoceptor agonists on the pulmonary vein arrhythmogenesis. Conventional microelectrodes were used to record the action potentials in isolated rabbit pulmonary vein tissue specimens before and after the administration of isoproterenol, phenylephrine and KN-93 (a calmodulin kinase II inhibitor). In the tissue preparation, isoproterenol (0, 0.1, 3 μM) increased the beating rates (1.5 ± 0.2, 1.6 ± 0.2, 2.3 ± 0.3 Hz, n = 10, P <0.001) with the genesis of early afterdepolarizations (EADs, 0%, 40%, 50%, P <0.05) and increased the amplitude of the delayed afterdepolarizations (DADs, 0.6 ± 0.3, 1.7 ± 0.4, 3.9 ± 1.0 mV, P <0.05). Phenylephrine (0, 1, 10 μM) also increased the beating rates (1.4 ± 0.2, 1.6 ± 0.2, 1.9 ± 0.2 Hz, n = 12, P <0.001), incidence of EADs (0%, 8%, 50%, P <0.05) and amplitude of the DADs (0.4 ± 0.2, 1.2 ± 0.4, 2.6 ± 0.8 mV, P <0.05). KN-93 did not change the pulmonary vein beating rates or action potential duration. However, in the presence of KN-93 (1 μM), isoproterenol (3 μM) and phenylephrine (10 μM) did not induce any EADs or DADs in the pulmonary veins. In conclusion, calmodulin kinase II inhibition may prevent adrenergic induced pulmonary vein arrhythmogenesis.

Original languageEnglish
Pages (from-to)197-208
Number of pages12
JournalEuropean Journal of Pharmacology
Volume571
Issue number2-3
DOIs
Publication statusPublished - Oct 1 2007

Fingerprint

Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Calcium-Calmodulin-Dependent Protein Kinases
Pulmonary Veins
Rabbits
Phenylephrine
Isoproterenol
Adrenergic Receptors
Action Potentials
Autonomic Agents
Calcium
Autonomic Nervous System
Microelectrodes
Calmodulin
Adrenergic Agents
Atrial Fibrillation
Homeostasis
Incidence
KN 93

Keywords

  • Adrenoceptor agonist
  • Atrial fibrillation
  • Calmodulin kinase II inhibitor
  • Pulmonary vein
  • Triggered activity

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins. / Lo, Li Wei; Chen, Yao Chang; Chen, Yi Jen; Wongcharoen, Wanwarang; Lin, Cheng I.; Chen, Shih Ann.

In: European Journal of Pharmacology, Vol. 571, No. 2-3, 01.10.2007, p. 197-208.

Research output: Contribution to journalArticle

Lo, Li Wei ; Chen, Yao Chang ; Chen, Yi Jen ; Wongcharoen, Wanwarang ; Lin, Cheng I. ; Chen, Shih Ann. / Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins. In: European Journal of Pharmacology. 2007 ; Vol. 571, No. 2-3. pp. 197-208.
@article{4ba9780e07e3432fbbbd4f0b6d69d1f4,
title = "Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins",
abstract = "The autonomic nervous system and calcium regulation play important roles in the pathophysiology of atrial fibrillation. Calmodulin regulates the calcium homeostasis and may mediate the proarrhythmic effects of autonomic nervous agents. The purpose of this study was to compare the effects of β- and α-adrenoceptor agonists on the pulmonary vein electrical activity and evaluate whether calmodulin kinase II inhibitors may change the effects of the adrenoceptor agonists on the pulmonary vein arrhythmogenesis. Conventional microelectrodes were used to record the action potentials in isolated rabbit pulmonary vein tissue specimens before and after the administration of isoproterenol, phenylephrine and KN-93 (a calmodulin kinase II inhibitor). In the tissue preparation, isoproterenol (0, 0.1, 3 μM) increased the beating rates (1.5 ± 0.2, 1.6 ± 0.2, 2.3 ± 0.3 Hz, n = 10, P <0.001) with the genesis of early afterdepolarizations (EADs, 0{\%}, 40{\%}, 50{\%}, P <0.05) and increased the amplitude of the delayed afterdepolarizations (DADs, 0.6 ± 0.3, 1.7 ± 0.4, 3.9 ± 1.0 mV, P <0.05). Phenylephrine (0, 1, 10 μM) also increased the beating rates (1.4 ± 0.2, 1.6 ± 0.2, 1.9 ± 0.2 Hz, n = 12, P <0.001), incidence of EADs (0{\%}, 8{\%}, 50{\%}, P <0.05) and amplitude of the DADs (0.4 ± 0.2, 1.2 ± 0.4, 2.6 ± 0.8 mV, P <0.05). KN-93 did not change the pulmonary vein beating rates or action potential duration. However, in the presence of KN-93 (1 μM), isoproterenol (3 μM) and phenylephrine (10 μM) did not induce any EADs or DADs in the pulmonary veins. In conclusion, calmodulin kinase II inhibition may prevent adrenergic induced pulmonary vein arrhythmogenesis.",
keywords = "Adrenoceptor agonist, Atrial fibrillation, Calmodulin kinase II inhibitor, Pulmonary vein, Triggered activity",
author = "Lo, {Li Wei} and Chen, {Yao Chang} and Chen, {Yi Jen} and Wanwarang Wongcharoen and Lin, {Cheng I.} and Chen, {Shih Ann}",
year = "2007",
month = "10",
day = "1",
doi = "10.1016/j.ejphar.2007.05.066",
language = "English",
volume = "571",
pages = "197--208",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins

AU - Lo, Li Wei

AU - Chen, Yao Chang

AU - Chen, Yi Jen

AU - Wongcharoen, Wanwarang

AU - Lin, Cheng I.

AU - Chen, Shih Ann

PY - 2007/10/1

Y1 - 2007/10/1

N2 - The autonomic nervous system and calcium regulation play important roles in the pathophysiology of atrial fibrillation. Calmodulin regulates the calcium homeostasis and may mediate the proarrhythmic effects of autonomic nervous agents. The purpose of this study was to compare the effects of β- and α-adrenoceptor agonists on the pulmonary vein electrical activity and evaluate whether calmodulin kinase II inhibitors may change the effects of the adrenoceptor agonists on the pulmonary vein arrhythmogenesis. Conventional microelectrodes were used to record the action potentials in isolated rabbit pulmonary vein tissue specimens before and after the administration of isoproterenol, phenylephrine and KN-93 (a calmodulin kinase II inhibitor). In the tissue preparation, isoproterenol (0, 0.1, 3 μM) increased the beating rates (1.5 ± 0.2, 1.6 ± 0.2, 2.3 ± 0.3 Hz, n = 10, P <0.001) with the genesis of early afterdepolarizations (EADs, 0%, 40%, 50%, P <0.05) and increased the amplitude of the delayed afterdepolarizations (DADs, 0.6 ± 0.3, 1.7 ± 0.4, 3.9 ± 1.0 mV, P <0.05). Phenylephrine (0, 1, 10 μM) also increased the beating rates (1.4 ± 0.2, 1.6 ± 0.2, 1.9 ± 0.2 Hz, n = 12, P <0.001), incidence of EADs (0%, 8%, 50%, P <0.05) and amplitude of the DADs (0.4 ± 0.2, 1.2 ± 0.4, 2.6 ± 0.8 mV, P <0.05). KN-93 did not change the pulmonary vein beating rates or action potential duration. However, in the presence of KN-93 (1 μM), isoproterenol (3 μM) and phenylephrine (10 μM) did not induce any EADs or DADs in the pulmonary veins. In conclusion, calmodulin kinase II inhibition may prevent adrenergic induced pulmonary vein arrhythmogenesis.

AB - The autonomic nervous system and calcium regulation play important roles in the pathophysiology of atrial fibrillation. Calmodulin regulates the calcium homeostasis and may mediate the proarrhythmic effects of autonomic nervous agents. The purpose of this study was to compare the effects of β- and α-adrenoceptor agonists on the pulmonary vein electrical activity and evaluate whether calmodulin kinase II inhibitors may change the effects of the adrenoceptor agonists on the pulmonary vein arrhythmogenesis. Conventional microelectrodes were used to record the action potentials in isolated rabbit pulmonary vein tissue specimens before and after the administration of isoproterenol, phenylephrine and KN-93 (a calmodulin kinase II inhibitor). In the tissue preparation, isoproterenol (0, 0.1, 3 μM) increased the beating rates (1.5 ± 0.2, 1.6 ± 0.2, 2.3 ± 0.3 Hz, n = 10, P <0.001) with the genesis of early afterdepolarizations (EADs, 0%, 40%, 50%, P <0.05) and increased the amplitude of the delayed afterdepolarizations (DADs, 0.6 ± 0.3, 1.7 ± 0.4, 3.9 ± 1.0 mV, P <0.05). Phenylephrine (0, 1, 10 μM) also increased the beating rates (1.4 ± 0.2, 1.6 ± 0.2, 1.9 ± 0.2 Hz, n = 12, P <0.001), incidence of EADs (0%, 8%, 50%, P <0.05) and amplitude of the DADs (0.4 ± 0.2, 1.2 ± 0.4, 2.6 ± 0.8 mV, P <0.05). KN-93 did not change the pulmonary vein beating rates or action potential duration. However, in the presence of KN-93 (1 μM), isoproterenol (3 μM) and phenylephrine (10 μM) did not induce any EADs or DADs in the pulmonary veins. In conclusion, calmodulin kinase II inhibition may prevent adrenergic induced pulmonary vein arrhythmogenesis.

KW - Adrenoceptor agonist

KW - Atrial fibrillation

KW - Calmodulin kinase II inhibitor

KW - Pulmonary vein

KW - Triggered activity

UR - http://www.scopus.com/inward/record.url?scp=34548595644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548595644&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2007.05.066

DO - 10.1016/j.ejphar.2007.05.066

M3 - Article

VL - 571

SP - 197

EP - 208

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -